Neil Desai, Executive Chairman, 10% Owner at Aadi Bioscience, Inc. (AADI), sold 2,305 shares at $7.57 ($17K) on 2023-05-04, disclosed to the SEC on 2023-05-05.
Scheduled sale ($17k) by Executive Chairman, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |